Stay updated on FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Sign up to get notified when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.

Latest updates to the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe FRIDA study (NCT05546580) updated its recruitment status from Recruiting to Active, not recruiting, with a new note that no participants are being sought. The record also adds/updates the Contacts/Locations and Study Status sections and shows a new revision (v3.6.6).SummaryDifference1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe record history now shows a new latest revision labeled v3.6.5. This replaces the previous v3.6.4 and reflects an update to the page's revision metadata.SummaryDifference0.1%

- Check44 days agoChange DetectedNew status-related fields and sponsor information appear in the study record history (Unknown status, Last known status was, Last verified, 2024-07, Oryzon Genomics S.A., Recruitment Status). Deletions remove Find Contact Information and Check who can join from the page.SummaryDifference0.8%

- Check51 days agoChange DetectedA new revision entry v3.6.4 was added to the Study Record Versions history, and the previous revision v3.6.3 was removed from the list, reflecting an update to the study's version history.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry labeled v3.6.3 was added to the study record history, and the prior revision v3.6.2 was removed from the list.SummaryDifference0.1%

- Check80 days agoChange DetectedThe study record history adds a new revision entry (v3.6.2) indicating a small update to the page, while the previous revision (v3.6.0) is removed in this change.SummaryDifference0.1%

Stay in the know with updates to FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Enter your email address, and we'll notify you when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.